RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 116 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,736,000 | -61.2% | 639,471 | -76.8% | 0.00% | -60.0% |
| Q2 2016 | $14,786,000 | +13.1% | 2,753,499 | -3.1% | 0.01% | +25.0% |
| Q1 2016 | $13,076,000 | -14.8% | 2,842,765 | -3.7% | 0.00% | 0.0% |
| Q4 2015 | $15,347,000 | -11.2% | 2,951,286 | +3.3% | 0.00% | -20.0% |
| Q3 2015 | $17,291,000 | -59.7% | 2,857,864 | +5.1% | 0.01% | -61.5% |
| Q2 2015 | $42,943,000 | +52.1% | 2,719,650 | +4.7% | 0.01% | +44.4% |
| Q1 2015 | $28,238,000 | -0.5% | 2,597,754 | -3.8% | 0.01% | +12.5% |
| Q4 2014 | $28,393,000 | +37.4% | 2,698,986 | +25.3% | 0.01% | +33.3% |
| Q3 2014 | $20,657,000 | -53.8% | 2,154,120 | -44.4% | 0.01% | -57.1% |
| Q2 2014 | $44,758,000 | +59.8% | 3,875,182 | +38.4% | 0.01% | +55.6% |
| Q1 2014 | $28,008,000 | -25.6% | 2,800,755 | -3.1% | 0.01% | -25.0% |
| Q4 2013 | $37,643,000 | +19608.4% | 2,891,155 | +22492.4% | 0.01% | – |
| Q3 2013 | $191,000 | -26.0% | 12,797 | -53.6% | 0.00% | – |
| Q2 2013 | $258,000 | +171.6% | 27,562 | +69.4% | 0.00% | – |
| Q4 2012 | $95,000 | -12.8% | 16,267 | -17.0% | 0.00% | – |
| Q3 2012 | $109,000 | -9.9% | 19,610 | -9.5% | 0.00% | – |
| Q2 2012 | $121,000 | +59.2% | 21,658 | +92.6% | 0.00% | – |
| Q1 2012 | $76,000 | – | 11,244 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|